ArticleMolecular therapy oncolytics2021

PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer.

Hongwei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.